Apixaban as an alternative to warfarin for patients with a left ventricular assist device

Am J Health Syst Pharm. 2022 May 24;79(11):826-829. doi: 10.1093/ajhp/zxac028.
No abstract available

Keywords: anticoagulation; apixaban; case series; direct oral anticoagulants; left ventricular assist device; warfarin.

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Anticoagulants / therapeutic use
  • Atrial Fibrillation* / drug therapy
  • Heart-Assist Devices*
  • Humans
  • Pyrazoles / therapeutic use
  • Pyridones / therapeutic use
  • Rivaroxaban / therapeutic use
  • Stroke* / drug therapy
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Pyrazoles
  • Pyridones
  • apixaban
  • Warfarin
  • Rivaroxaban